• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黑色素瘤的莫氏显微外科手术的当前观点

Current perspectives on Mohs micrographic surgery for melanoma.

作者信息

Beaulieu Derek, Fathi Ramin, Srivastava Divya, Nijhawan Rajiv I

机构信息

Tufts University School of Medicine, Boston, MA.

Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

出版信息

Clin Cosmet Investig Dermatol. 2018 Jun 20;11:309-320. doi: 10.2147/CCID.S137513. eCollection 2018.

DOI:10.2147/CCID.S137513
PMID:29950878
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6016488/
Abstract

Mohs micrographic surgery (MMS), a specialized surgical excision technique used primarily in the treatment of skin cancers, is tissue sparing and provides optimal margin control through evaluation of 100% of both the peripheral and deep margin. The use of MMS for the treatment of malignant melanoma (MM) and melanoma in situ (MIS) has been slow in gaining the same widespread acceptance that it has for keratinocyte carcinomas despite its cost-effectiveness and the growing body of evidence demonstrating similar or improved cure rates to standard wide local excision. However, modern advances in immunohistochemical staining have continued to greatly enhance the ability of Mohs surgeons to interpret MMS frozen sections of melanoma specimens - the primary concern of most opponents of MMS for melanoma. These advances, coupled with an increased recognition by professional organizations of the utility of MMS in treating MM and MIS, have led to a rise in the use of MMS for melanoma in recent years. Given the expanding role of MMS in the treatment of cutaneous melanoma, this manuscript will describe how MMS is performed, discuss the rationale and current evidence regarding the use of MMS for MM and MIS, review the immunohistochemical stains currently available for use in MMS, and consider special situations and future directions in this area of growing interest.

摘要

莫氏显微外科手术(MMS)是一种主要用于治疗皮肤癌的专业手术切除技术,它能够保留组织,并通过对100%的周边和深部切缘进行评估来实现最佳的切缘控制。尽管MMS具有成本效益,且越来越多的证据表明其治愈率与标准的广泛局部切除相似或更高,但与用于治疗角质形成细胞癌相比,MMS用于治疗恶性黑色素瘤(MM)和原位黑色素瘤(MIS)的应用在获得广泛认可方面进展缓慢。然而,免疫组织化学染色方面的现代进展继续极大地提高了莫氏外科医生解读黑色素瘤标本MMS冰冻切片的能力——这是大多数反对将MMS用于黑色素瘤治疗的人主要关注的问题。这些进展,再加上专业组织对MMS在治疗MM和MIS中的效用的认可度提高,导致近年来MMS在黑色素瘤治疗中的应用有所增加。鉴于MMS在皮肤黑色素瘤治疗中的作用不断扩大,本文将描述MMS的操作方法,讨论使用MMS治疗MM和MIS的基本原理和当前证据,回顾目前可用于MMS的免疫组织化学染色,并考虑这一日益受关注领域的特殊情况和未来方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/119a/6016488/9e4610ef576b/ccid-11-309Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/119a/6016488/ff8b8f81c50f/ccid-11-309Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/119a/6016488/dc10690e0d48/ccid-11-309Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/119a/6016488/9e4610ef576b/ccid-11-309Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/119a/6016488/ff8b8f81c50f/ccid-11-309Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/119a/6016488/dc10690e0d48/ccid-11-309Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/119a/6016488/9e4610ef576b/ccid-11-309Fig3.jpg

相似文献

1
Current perspectives on Mohs micrographic surgery for melanoma.黑色素瘤的莫氏显微外科手术的当前观点
Clin Cosmet Investig Dermatol. 2018 Jun 20;11:309-320. doi: 10.2147/CCID.S137513. eCollection 2018.
2
Mohs micrographic surgery for melanoma: a case series, a comparative study of immunostains, an informative case report, and a unique mapping technique.黑色素瘤的莫氏显微外科手术:病例系列、免疫染色对比研究、一份信息丰富的病例报告及一种独特的定位技术。
Dermatol Surg. 2002 Aug;28(8):656-65. doi: 10.1046/j.1524-4725.2002.02024.x.
3
Mohs micrographic surgery in the surgical treatment paradigm of melanoma in situ and invasive melanoma: A clinical review of treatment efficacy and ongoing controversies.Mohs 显微外科手术在原位黑色素瘤和侵袭性黑色素瘤的手术治疗模式中的应用:治疗效果的临床评价和持续存在的争议。
J Am Acad Dermatol. 2024 Sep;91(3):499-507. doi: 10.1016/j.jaad.2024.05.024. Epub 2024 May 19.
4
Outcomes of Melanoma In Situ Treated With Mohs Micrographic Surgery Compared With Wide Local Excision.莫氏显微外科手术与广泛局部切除治疗原位黑色素瘤的疗效比较
JAMA Dermatol. 2017 May 1;153(5):436-441. doi: 10.1001/jamadermatol.2016.6138.
5
The Current State of Mohs Surgery for the Treatment of Melanoma: A Nationwide Cross-Sectional Survey of Mohs Surgeons.《莫氏手术治疗黑色素瘤的现状:对莫氏外科医生的全国性横断面调查》。
Dermatol Surg. 2020 Oct;46(10):1267-1271. doi: 10.1097/DSS.0000000000002645.
6
The use of Mohs micrographic surgery (MMS) for melanoma in situ (MIS) of the trunk and proximal extremities.在躯干和近端肢体原位黑色素瘤(MIS)中使用Mohs 显微外科手术(MMS)。
J Am Acad Dermatol. 2016 Nov;75(5):1015-1021. doi: 10.1016/j.jaad.2016.06.033. Epub 2016 Jul 26.
7
An Update and Review of Clinical Outcomes Using Immunohistochemical Stains in Mohs Micrographic Surgery for Melanoma.利用免疫组织化学染色在Mohs 显微外科手术中治疗黑色素瘤的临床结果更新和回顾。
Dermatol Surg. 2024 Jan 1;50(1):9-15. doi: 10.1097/DSS.0000000000003945. Epub 2023 Sep 18.
8
Cost effectiveness of Mohs micrographic surgery: review of the literature.莫氏显微外科手术的成本效益:文献综述
J Drugs Dermatol. 2009 Oct;8(10):914-22.
9
Mohs Micrographic Surgery: Past, Present, and Future.莫氏显微外科手术:过去、现在与未来。
Dermatol Surg. 2019 Mar;45(3):329-339. doi: 10.1097/DSS.0000000000001701.
10
Mohs micrographic surgery is accurate 95.1% of the time for melanoma in situ: a prospective study of 167 cases.对于原位黑色素瘤,莫氏显微外科手术的准确率为95.1%:一项167例病例的前瞻性研究。
Dermatol Surg. 2008 May;34(5):660-4. doi: 10.1111/j.1524-4725.2007.34124.x. Epub 2008 Feb 6.

引用本文的文献

1
Mohs micrographic surgery for the treatment of invasive melanoma: A systematic review with meta-analyses.莫氏显微外科手术治疗浸润性黑色素瘤:一项荟萃分析的系统评价
J Eur Acad Dermatol Venereol. 2025 Feb;39(2):416-425. doi: 10.1111/jdv.20138. Epub 2024 Jun 6.
2
Comparative Analysis of Slow Mohs Surgery in Melanoma and Mohs Micrographic Surgery in Squamous Cell Carcinoma and Basal Cell Carcinoma.黑色素瘤中慢速莫氏手术与鳞状细胞癌和基底细胞癌中莫氏显微手术的对比分析
Cureus. 2024 May 5;16(5):e59693. doi: 10.7759/cureus.59693. eCollection 2024 May.
3
Double Immunohistochemical Labelling of PRAME and Melan A in Slow Mohs Biopsy Margin Assessment of Lentigo Maligna and Lentigo Maligna Melanoma.

本文引用的文献

1
Mohs micrographic surgery and dermatopathology concordance: An analysis of 1421 Mohs cases over 17 years.Mohs 显微外科手术与皮肤病理诊断符合率:17 年间 1421 例病例分析。
J Am Acad Dermatol. 2023 Jan;88(1):118-122. doi: 10.1016/j.jaad.2017.11.055. Epub 2017 Dec 13.
2
Histologic Accuracy of Mohs Micrographic Surgery.莫氏显微外科手术的组织学准确性。
Dermatol Surg. 2018 Mar;44(3):350-353. doi: 10.1097/DSS.0000000000001352.
3
Amelanotic Lentigo Maligna Melanoma: Mohs Surgery as the Definitive Treatment of an Invisible Tumour.
在评估恶性雀斑样痣和恶性雀斑样痣黑素瘤的慢切组织边缘时,PRAME 和 Melan A 的双重免疫组织化学标记。
Br J Biomed Sci. 2024 Mar 19;81:12319. doi: 10.3389/bjbs.2024.12319. eCollection 2024.
4
MMS hotspots: a cross-sectional comparison of U.S. counties with and without Mohs micrographic surgery.MMS 热点:美国有和没有 Mohs 显微外科手术的县的横断面比较。
Arch Dermatol Res. 2023 Dec 7;316(1):21. doi: 10.1007/s00403-023-02751-x.
5
New Treatment Horizons in Uveal and Cutaneous Melanoma.葡萄膜和皮肤黑色素瘤的新治疗前景
Life (Basel). 2023 Jul 31;13(8):1666. doi: 10.3390/life13081666.
6
Challenges in the Complex Management of Neglected Cutaneous Melanomas in the Head and Neck Area: A Single Center Experience.头颈部隐匿性皮肤黑色素瘤复杂管理中的挑战:单中心经验
J Clin Med. 2023 Feb 28;12(5):1910. doi: 10.3390/jcm12051910.
7
Mohs Micrographic Surgery for Melanoma: A Convincing Treatment Modality.用于黑色素瘤的莫氏显微外科手术:一种令人信服的治疗方式。
Indian J Dermatol. 2022 Jul-Aug;67(4):479. doi: 10.4103/ijd.ijd_1074_20.
8
Evidence from Clinical Studies Related to Dermatologic Surgeries for Skin Cancer.与皮肤癌皮肤科手术相关的临床研究证据。
Cancers (Basel). 2022 Aug 8;14(15):3835. doi: 10.3390/cancers14153835.
9
Effect of the COVID-19 Pandemic on Delayed Skin Cancer Services.COVID-19 大流行对延迟性皮肤癌服务的影响。
Dermatol Clin. 2021 Oct;39(4):627-637. doi: 10.1016/j.det.2021.05.015. Epub 2021 May 28.
10
Association of Treatment Facility Characteristics With Overall Survival After Mohs Micrographic Surgery for T1a-T2a Invasive Melanoma.治疗设施特征与 T1a-T2a 浸润性黑色素瘤Mohs 显微外科手术后总生存的关联。
JAMA Dermatol. 2021 May 1;157(5):531-539. doi: 10.1001/jamadermatol.2021.0023.
无色素性恶性雀斑样痣黑素瘤:莫氏手术作为隐匿性肿瘤的确定性治疗方法
J Cutan Med Surg. 2018 Jan/Feb;22(1):51-57. doi: 10.1177/1203475417719046. Epub 2017 Jul 7.
4
A Retrospective Case-Matched Cost Comparison of Surgical Treatment of Melanoma and Nonmelanoma Skin Cancer in the Outpatient Versus Operating Room Setting.门诊与手术室环境下黑色素瘤和非黑色素瘤皮肤癌手术治疗的回顾性病例匹配成本比较
Dermatol Surg. 2017 Jul;43(7):897-901. doi: 10.1097/DSS.0000000000001069.
5
Outcomes of Melanoma In Situ Treated With Mohs Micrographic Surgery Compared With Wide Local Excision.莫氏显微外科手术与广泛局部切除治疗原位黑色素瘤的疗效比较
JAMA Dermatol. 2017 May 1;153(5):436-441. doi: 10.1001/jamadermatol.2016.6138.
6
The value of reflectance confocal microscopy in diagnosis of flat pigmented facial lesions: a prospective study.反射式共聚焦显微镜在诊断扁平色素性面部病变中的价值:一项前瞻性研究。
J Eur Acad Dermatol Venereol. 2017 Aug;31(8):1349-1354. doi: 10.1111/jdv.14171. Epub 2017 May 15.
7
Clinical factors associated with subclinical spread of in situ melanoma.与原位黑色素瘤的临床扩散相关的临床因素。
J Am Acad Dermatol. 2017 Apr;76(4):707-713. doi: 10.1016/j.jaad.2016.10.049. Epub 2017 Jan 7.
8
NCCN Guidelines Insights: Melanoma, Version 3.2016.NCCN 指南解读:黑色素瘤,第 3.2016 版。
J Natl Compr Canc Netw. 2016 Aug;14(8):945-58. doi: 10.6004/jnccn.2016.0101.
9
The use of Mohs micrographic surgery (MMS) for melanoma in situ (MIS) of the trunk and proximal extremities.在躯干和近端肢体原位黑色素瘤(MIS)中使用Mohs 显微外科手术(MMS)。
J Am Acad Dermatol. 2016 Nov;75(5):1015-1021. doi: 10.1016/j.jaad.2016.06.033. Epub 2016 Jul 26.
10
Mohs Micrographic Surgery Using MART-1 Immunostain in the Treatment of Invasive Melanoma and Melanoma In Situ.使用MART-1免疫染色的莫氏显微外科手术治疗侵袭性黑色素瘤和原位黑色素瘤。
Dermatol Surg. 2016 Jun;42(6):733-44. doi: 10.1097/DSS.0000000000000725.